Form 4 for ANAB ANAPTYSBIO, INC
Accepted 2024-06-18 00:00:00 ET · period of report 2024-06-15 · accession 0001415889-24-017508 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-18 | 2024-06-15 | ANAB | Orwin John A | Dir | M - OptEx | $0.00 | +2,035 | 2,035 | New | $0 |
| D | 2024-06-18 | 2024-06-15 | ANAB | Orwin John A | Dir | M - OptEx | $0.00 | -2,035 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-15 | M | A | 2,035 | $0.00 | 2,035 | D | — | — | (F1) Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. |
| 2 | Derivative | Restricted Stock Unit | 2024-06-15 | M | D | 2,035 | $0.00 | 0 | D | — · — to — | 2,035 Common Stock | (F1) Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. (F2) The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2024 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date. |